Across TCGA pan-cancer cohorts, HAUS7 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated HAUS7 data layer compared with 23 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher HAUS7 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated HAUS7 expression acts as an unfavorable survival marker, although some lineages such as LSCC and LUAD show a favorable association.

CCRCC, LSCC, and LUAD are the cancer types where HAUS7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Quartile	All	0.616	0.885	.007	19	view →
LSCC	OS	Median	All	0.904	0.685	.004	8	view →
LUAD	DFS	Quartile	II,III,IV	0.727	0.407	.029	4	view →
HNSC	OS	Median	All	0.801	0.909	.017	4	view →
UCEC	DFS	Median	All	0.935	1.000	.020	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: HAUS7 tumor-vs-normal RNA expression · all HAUS7 data types